N
NeOnc Technologies Holdings, Inc. (NTHI)
NGM – Real vaqt narxi. Valyuta: USD
5.51
+0.01 (0.18%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NGM – Real vaqt narxi. Valyuta: USD
5.51
+0.01 (0.18%)
Yopilishda: May 12, 2026, 4:00 PM EDT
NeOnc Technologies Holdings, Inc., klinik bosqichdagi biofarmatsevtika kompaniyasi, bosh miya o'smalarini davolashni ishlab chiqishga qaratilgan. Uning asosiy mahsulot nomzodlari orasida klinik tadqiqotning IIa bosqichida bo'lgan preillyl kislotasining tozalanmagan shakli NEO100; va meningioma, yuqori darajali glial o'smalar, glioblastoma kabi birlamchi miya saratonini davolash uchun og'iz orqali yuborish uchun I/II bosqichli klinik tadqiqotlarda bo'lgan kimyoterapiya preparati temozolomidni perillyl alkogol bilan kovalent bog'langan molekula NEO212 mavjud. Kompaniya ilgari NAS-ONC, Inc. nomi bilan tanilgan va 2009 yilda NeOnc Technologies Holdings, Inc. nomini o'zgartirgan. Kompaniya 2005 yilda tashkil etilgan va shtab-kvartirasi Kalabasas, Kaliforniyada joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Josh Neman-Ebrahim Ph.D. | Chief Clinical Officer |
| Dr. Thomas C. Chen M.D., Ph.D. | Founder, Chief Medical Officer, Chief Scientific Officer & Vice Chairman |
| Mr. Amir Farrokh Heshmatpour | President, CEO, Executive Chairman & Secretary |
| Mr. David Choi Jr. | Chief Accounting Officer |
| Mr. Keithly A. Garnett | Chief Financial Officer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-05-05 | 10-K/A | neonctechnologies_10ka.htm |
| 2026-04-24 | 8-K | neonctechnologies_8k.htm |
| 2026-04-16 | 8-K | neonctechnologies_8k.htm |
| 2026-04-10 | S-3 | neonctechnologies_s3.htm |
| 2026-04-07 | CORRESP | filename1.htm |
| 2026-04-03 | 8-K | neonctechnologies_8k.htm |
| 2026-04-02 | S-3 | neonctechnologies_s3.htm |
| 2026-03-31 | 10-K | neonctechnologies_10k.htm |
| 2026-03-23 | 8-K | neonctechnologies_8k.htm |
| 2026-03-17 | 8-K | neonctechnologies_8k.htm |